Oncobiologics, Inc. (ONS) SEC Filing 8-K Material Event for the period ending Wednesday, July 18, 2018

Oncobiologics, Inc.

CIK: 1649989 Ticker: ONS

View differences made from one to another to evaluate Oncobiologics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Oncobiologics, Inc..


Assess how Oncobiologics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Oncobiologics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Oncobiologics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ONS
CIK: 1649989
Form Type: 8-K Corporate News
Accession Number: 0001571049-18-000405
Submitted to the SEC: Thu Jul 19 2018 4:34:11 PM EST
Accepted by the SEC: Thu Jul 19 2018
Period: Wednesday, July 18, 2018
Industry: Biological Products No Disgnostic Substances
  1. Bylaw Change
  2. Financial Exhibit
  3. New Agreement
  4. Other Events
  5. Security Holders Change
  6. Unregistered Sales
  7. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: